NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of RNA isolation and associated methods for extracellular RNA detection by high-throughput quantitative polymerase chain reaction.

Author(s): Tanriverdi K, Kucukural A, Mikhalev E, Tanriverdi SE, Lee R, Ambros VR, Freedman JE

Publication: Anal Biochem, 2016, Vol. 501, Page 66-74

PubMed ID: 26969789 PubMed Review Paper? No

Purpose of Paper

This paper examined extraction of RNA from plasma using four different methods and compared yields and microRNA (miRNA) cycle threshold (CT) values. The effect of using serum versus plasma, reverse transcription and preamplification method, and assay type on CT values were examined using RNA isolated with the preferred extraction method.

Conclusion of Paper

The highest RNA yields were obtained using the miRNeasy Serum/Plasma kit followed by the miRCURY RNA Isolation kit, and the lowest average cycle threshold (CT) values were obtained using the in-house method and the TaqMan miRNA ABC kit. However, the CT values were strongly correlated among all of the isolation kits. As the coefficient of variance for each of the three replicates and the cumulative distribution of CT values were lowest when extraction was with the in-house method, this extraction method was selected for the remaining studies. CT values were lower for serum than for plasma, when reverse transcription was with the miScript II RT kit rather than the TaqMan microRNA RT kit, when preamplification was with the miScript Microfluidic PreAmp kit rather than the TaqMan preamp kit, and when miScript miRNA assays were used rather than TaqMan miRNA assays.

Studies

  1. Study Purpose

    This study examined extraction of RNA from plasma using four different methods and compared yields and miRNA CT­ values. Blood was collected by venipuncture from three healthy males and three healthy females into sodium citrate tubes. Specimens were centrifuged immediately at 2000 x g for 10 min and plasma was transferred to microcentrifuge tubes and centrifuged again at 8000 x g for 10 min. The resultant supernatant was pooled in new tubes, aliquoted, and stored at -80˚C until RNA isolation. RNA was isolated using the miRCURY RNA isolation kit, the miRNeasy serum/plasma kit, the TaqMan miRNA ABC purification kit, and an in-house method based on phenol/chloroform extraction. RNA quality was assessed by the Agilent RNA 6000 Pico Kit and the Agilent Small RNA Kit on a bioanalyzer. RNA was reverse transcribed using miScript II RT Kit, preamplified using the miScript Microfluidics PreAMP kit, and quantified using 90 miScript miRNA real-time PCR assays.

    Summary of Findings:

    The Agilent Small RNA kit was unable to quantify RNA in any of the specimens. Using the Agilent RNA 6000 Pico Kit, the highest RNA yields were obtained using the miRNeasy Serum/Plasma kit (9.20 ± 3.12 ng) followed by the miRCURY RNA Isolation kit (7.36 ± 2.07 ng) and much lower yields obtained using the in-house method (1.06 ± 0.44 ng) and TaqMan miRNA ABC kit (0.70 ± 0.26 ng).  In contrast, the lowest average cycle threshold (CT) values were obtained using the in-house method (17.25 ± 0.41) and TaqMan miRNA ABC kit (17.27 ± 1.135) followed by the miRCURY RNA isolation (18.20 ± 0.955) and miRNEasy Serum/Plasma kit (19.17 ± 0.73). The coefficient of variance for each of the three replicates for the 90 gene panel was lower when extraction was with the in-house method (1.86%) than when the miRNEasy (3.77%), miRCURY (5.10%), or TaqMan (6.75%) kits were used. Further, the lowest cumulative distribution of CT values was found when the in-house method was used for extraction and the highest when the miRNEasy kit was used. Importantly, the CT values were strongly correlated among all of the isolation kits (ρ=0.88-0.96).

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    RNA Automated electrophoresis/Bioanalyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Analyte Extraction and Purification Analyte isolation method miRCURY RNA isolation kit
    miRNeasy serum/plasma kit
    TaqMan miRNA ABC purification kit
    In-house method
  2. Study Purpose

    This study compared CT values between serum and plasma and investigated the effects of using the miScript versus TaqMan kit for reverse transcription, preamplification, and quantification of miRNA. Blood was collected by venipuncture from three healthy males and three healthy females into sodium citrate and serum tubes. Citrated specimens were centrifuged immediately at 2000 x g for 10 min and serum tubes were allowed to clot for 30 min and centrifuged at 2000 x g for 10 min. Plasma and serum were transferred to microcentrifuge tubes, centrifuged again at 8000 x g for 10 min, and the supernatants were pooled in new tubes and then aliquoted. Pooled serum and plasma aliquots were stored at -80˚C until RNA isolation using an in-house method based on phenol/chloroform extraction. RNA quality was assessed by the Agilent RNA 6000 Pico Kit on a bioanalyzer. RNA was reverse transcribed using miScript II RT Kit and TaqMan MicroRNA RT kit. cDNA was preamplified using the miScript Microfluidics PreAMP kit and the TaqMan PreAMP kit. miRNAs were quantified using 90 miScript miRNA or TaqMan real-time PCR assays.

    Summary of Findings:

    The mean CT values were lower for serum than plasma using either the miScript RT kit (18.05 versus 19.29) or the TaqMan MicroRNA RT kit (21.25 versus 22.40) for reverse transcription. Preamplification with the miScript microfluidics kit resulted in lower mean CT values than the TaqMan PreAMP Master Mix for plasma (19.11-19.51 and 22.17-22.63, respectively) and serum (18.01-18.11 and 20.82-21.58, respectively). The correlations between replicates were higher when the miScript miRNA assays were used rather than the TaqMan miRNA assays for plasma (ρ=0.88-0.97 versus ρ=0.31-0.94) and serum (ρ=0.97-0.99 versus ρ=0.77-0.97). Finally, the distribution of CT values differed among the assays and specimen types with the miScript miRNA assay having distributions of 6-27 for plasma and 5-27 for serum and the TaqMan miRNA assay having distributions of 14-27 for plasma and 7-27 for serum.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    RNA Automated electrophoresis/Bioanalyzer
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Serum
    Plasma
    Real-time qRT-PCR Specific Template modification Reverse transcribed with miScript
    Preamplified with miScript kit
    Preamplified with TaqMan kit
    Reverse transcribed with TaqMan kit
    Real-time qRT-PCR Specific Technology platform TaqMan assays
    miScript assays

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...